MissionIR Articles

VirtualScopics is a leader in providing quantitative imaging solutions that accelerate drug and medical device development. The company has developed a robust software platform for analyzing and modeling both structural and functional medical images. In…

Cyclacel Pharmaceuticals is a biopharmaceutical company focused on developing oral therapies that target the various cell cycle control phases to treat cancer and other serious diseases. Sapacitabine, the company’s most advanced oral product candidate, is…

Opexa Therapeutics is a biotechnology company focused on developing patient-specific cellular therapies for treating autoimmune diseases like MS. Tcelna, the company’s leading therapy, is a personalized cellular immunotherapy treatment currently in clinical development to target…

Novelos Therapeutics is a pharmaceutical company engaged in the development of novel drugs to treat and diagnose cancer. The company’s cancer-targeted compounds are selectively taken up and retained in cancer cells – including cancer stem…

NeoStem is focused on developing and building on its core capabilities in cell therapy, to capitalize on the burgeoning cell therapy industry as well as cell therapy’s future role in the fight against chronic disease;…

Cleveland BioLabs is a clinical-stage biotechnology company focused on leveraging deep mechanistic understanding of apoptosis – the cell death process – to develop a strong pipeline of compounds chiefly focused on oncology applications and mitigation…

Zealand Pharma is a Copenhagen, Denmark-based biotechnology company specializing in the discovery, optimization and development of novel peptide drugs. The company has an expansive and mature pipeline of drug candidates that have been identified through…

Biotie Therapies is a specialized drug development company engaged in the development of drugs to address diseases of high unmet medical need and significant market potential, including neurodegenerative and psychiatric disorders and inflammatory and fibrotic…

Cytokinetics is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule therapeutics that modulate muscle function to potentially treat serious diseases and medical conditions. The company has various drug candidates at different…

ProMetic Life Sciences is a worldwide biopharmaceutical company that specializes in designing small molecules that mimic unique and specific interactions between proteins, research, development, manufacturing and marketing of various commercial applications derived from its proprietary…

Atossa Genetics, known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to…

Targacept is a clinical-stage biopharmaceutical company engaged in developing a varied pipeline of innovative NNR therapeutics for hard-to-treat nervous system diseases and disorders. The company’s clinical pipeline includes multiple Phase 2 product candidates that all…

  Provectus Pharmaceuticals is a biopharmaceutical company specializing in the development of oncology and dermatology therapies. PV-10, the company’s novel oncology drug, is designed to selectively target and destroy cancer cells without harming the surrounding…

NovaBay Pharmaceuticals is a biotechnology company engaged in using its two distinct categories of product offerings – Aganocides and NeutroPhase Skin and Wound Cleanser – to address the large, unmet therapeutic needs of the worldwide…

Agenus is a biotechnology company engaged in developing treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, with multiple product candidates advancing through the clinic, including…

Tonix Pharmaceuticals Holding is focused on the development of innovative prescription medicines for challenging disorders of the central nervous system. Tonix targets conditions characterized by significant unmet medical need, inadequate existing treatments and high patient…

Palatin Technologies is a biopharmaceutical company engaged in the development of targeted, receptor-specific peptide therapeutics for treating diseases that have significant unmet medical need but where there is also commercial potential. The company’s strategy involves…

Lexicon Pharmaceuticals is a biopharmaceutical company engaged in the discovery of breakthrough treatments for human disease. Currently, the company has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid…

CEL-SCI is a biotechnology company engaged in research and development directed toward improving treatments for cancer and other diseases through utilization of the immune system – the body’s natural defense system. Multikine, the company’s lead…